Picture of DNA strand

Pioneering chemical biology & medicinal chemistry through Open Access research...

Strathprints makes available scholarly Open Access content by researchers in the Department of Pure & Applied Chemistry, based within the Faculty of Science.

Research here spans a wide range of topics from analytical chemistry to materials science, and from biological chemistry to theoretical chemistry. The specific work in chemical biology and medicinal chemistry, as an example, encompasses pioneering techniques in synthesis, bioinformatics, nucleic acid chemistry, amino acid chemistry, heterocyclic chemistry, biophysical chemistry and NMR spectroscopy.

Explore the Open Access research of the Department of Pure & Applied Chemistry. Or explore all of Strathclyde's Open Access research...

Editorial : corporate entrepreneurship

Monsen, Erik and Peters, Sascha (2010) Editorial : corporate entrepreneurship. International Journal of Entrepreneurial Venturing, 2 (2). pp. 107-113. ISSN 1742-5360

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

In this special issue of IJEV, we endeavour to broaden the conversation around and our understanding of entrepreneurial initiatives which begin inside existing organisations, ranging from entrepreneurial acts of individual employees to strategic renewal of the entire organisation. When we announced this special issue, we provided an initial working definition for corporate entrepreneurship as “the process whereby an individual or group of individuals, in association with an existing organisation, create a new organisation or instigate renewal or innovation within that organisation” [Sharma and Chrisman, (1999), p.18]. Furthermore, we claimed that these processes and actions need to be proactive, innovative, and involve risk-taking in order to be considered entrepreneurial (Miller, 1983). In addition, we cast a wide net, stating that the goals of these actions can be long-term “organisational development” and “cultural change”, mid-term “strategic benefits” and “real-option development”, and short-term “quick financial returns” [Miles and Covin, (2002), p.34].